Related Experiment Video
Updated: Oct 3, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients
N Hernández-Becerril1, A Nava, P A Reyes
1Laboratorio de Inmunoparasitología, Instituto Nacional de Cardiología I. Chávez, INCICH, Juan Badiano No. 1, 14080 México D.F.
Background:
The anti-Trypanosoma cruzi antibodies isotype profile in Chagas' disease has been studied in relation to different clinical manifestations. A high titer of IgG anti-T. cruzi antibodies is found in patients with cardiac involvement, while a high titer of IgA anti-T. cruzi antibodies is associated with digestive forms.
Objective:
The aim of this work was to analyze the IgG subclass reactivity of anti-T. cruzi antibodies in patients with chronic Chagasic cardiomyopathy.
Methods:
Twelve consecutive chagasic patients were analyzed for IgG subclass reactivity to a T. cruzi antigenic extract. They had a complete clinical evaluation, peripheral EKG, echocardiography, left ventriculogram, and coronariography.
Results:
All patients came from rural areas of Mexico and had lived in endemic zones for over seven years. They presented left ventricular endsystolic dimension above 42 mm in 58% (7/12) and ejection fraction below 50% in 58% (7/12). We found that IgG1 and IgG2 anti-T. cruzi antibodies showed higher titer than IgG3 antibodies, with consistently low titer of IgG4 antibodies. Expression of the four IgG subclasses of anti-T. cruzi antibodies suggest a mixed Th1/Th2-like immune response under a probably continuous chronic antigenic stimulation. On the other hand, high levels of IgG2 anti-T. cruzi antibodies showed a tendency to be associated with severe cardiomegaly.
Conclusions:
Our results suggest that a mixed Th1/Th2-like immune response may take place in chronic chagasic patients under a chronic antigenic stimulation.
Related Concept Videos
American Trypanosomiasis
Antiprotozoal Agents
Leishmaniasis
Toxoplasmosis
Anthelminthic Agents
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

